Zahra H. Khan, MS, Yoshiko Iwai, MS, and Sayantani DasGupta, MD, MPH
In 2020, the authors of this article published “Abolition Medicine” as one contribution to international abolitionist conversations responding to widespread anti-Black police violence and inequity laid bare by the COVID-19 pandemic.
AMA J Ethics. 2022;24(3):E239-246. doi:
10.1001/amajethics.2022.239.
Dr Amy Watson joins Ethics Talk to discuss how crisis intervention teams can motivate efficiency and equity in tactical responses to 911 calls and what community mental health intervention might look like when we think beyond the limits of law enforcement response.
Leah M. Marcotte, MD, Jeffrey Krimmel-Morrison, MD, and Joshua M. Liao, MD, MSc
Individuals can underperform in circumstances of shared accountability. In clinical settings, this is an unintended consequence of the health care sector’s complexity fragmentation.
AMA J Ethics. 2020;22(9):E802-807. doi:
10.1001/amajethics.2020.802.
Sara Silbert, MD, Gregory A. Yanik, MD, and Andrew G. Shuman, MD
“Living” drugs target specific B-cell malignancy tumor antigens, but cost hundreds of thousands of dollars. Value analysis can help determine whether to offer these customized drugs.
AMA J Ethics. 2019;21(10):E844-851. doi:
10.1001/amajethics.2019.844.
Wandy D. Hernandez-Gordon, CD(DONA), BDT(DONA), CLC, CCE(ACBE)
CHWs’ work underscores need for clinicians and organizations to respond to deeply entrenched, long-standing patterns of oppression in ways that draw upon lived experience.
AMA J Ethics. 2022;24(4):E333-339. doi:
10.1001/amajethics.2022.333.
On this episode of Ethics Talk, Zahra H. Khan, Yoshiko Iwai, and Dr Sayantani DasGupta outline how “abolition medicine” can motivate critical responses to medicine’s expressions of hyper-punitive, deeply racialized exercises of state authority.